Our monthly report on AI, ML, DL, and NLP in healthcare looks at who, what, where, and how the use of artificial intelligence is changing healthcare for the better. We will bring you some of the latest news and product information along with thought leader posts and our AI playlist of episodes from Healthcare NOW Radio.
In the News
Waystar Accelerates Impact in Healthcare Payments with New Innovations on Cloud-Based Platform
Waystar (@Waystar), a provider of healthcare payments software, announced significant enhancements across the company’s award-winning, cloud-based platform. At a time of explosive growth in the accessibility and sophistication of technology, improved capabilities in areas such as artificial intelligence are playing a more significant role than ever in revolutionizing healthcare, particularly in administration and operations. Applied to the payments process, Waystar’s advances give patients and providers unparalleled clarity and accuracy, speed time to payment and connect processes and data to drive even higher levels of performance and insight.
Wolters Kluwer acquires U.S. AI-enabled drug diversion detection software
Wolters Kluwer Health (@Wolters_Kluwer) announced it has signed and completed the acquisition of Invistics Corporation (Invistics), a U.S.-based provider of cloud-based, AI-enabled software for drug diversion detection and controlled substance compliance. Invistics will join the company’s Clinical Surveillance, Compliance & Data Solutions unit, part of Clinical Solutions.
Reigniting the Cancer Moonshot: Massive Bio Joins CancerX as Founding Member to Accelerate Innovation and AI Implementation in Cancer Care
Massive Bio (@MassiveBio), a globally recognized company in the oncology space, has proudly announced its appointment as a founding member of CancerX, a groundbreaking initiative endorsed by The White House. This appointment situates Massive Bio at the forefront of a national public-private partnership aiming to revolutionize the fight against cancer. Spearheaded by the rejuvenated Cancer Moonshot initiative, CancerX is co-hosted by Moffitt Cancer Center and Digital Medicine Society (DiMe), bringing together diverse stakeholders to foster greater equity and reduce financial toxicity in cancer care and research.
Ezra Receives 510(k) FDA Clearance For AI That Enhances MRI, Enabling Fast, Low-Cost Scans
Ezra (@ezrainc), the healthcare AI startup transforming early cancer detection through full body MRI screening, announced that its newest proprietary Artificial Intelligence, Ezra Flash, has received 510(k) clearance by the U.S. Food and Drug Administration (FDA). Ezra Flash enhances the quality of MR images, making it possible for Ezra to decrease the time needed to complete a high quality scan, thereby reducing MRI cost. The company will use this technology to launch the world’s first 30 minute full body MRI scan.
St. Luke’s University Health Network Selects GE HealthCare for $30 Million Purchase of Cutting-Edge CT Technology, Powered by Artificial Intelligence
GE HealthCare (@GEHealthCare), a medical technology innovator, announced its largest ever CT deal in the United States – a $30 million order by St. Luke’s University Health Network, a nationally recognized nonprofit healthcare network, to install 21 of GE HealthCare’s innovative CT systems, powered by Artificial Intelligence (AI), across their system. This order builds upon the more than 30-year relationship between the two organizations.
For Canadian Pharmacies, AI Conquers a Mountain of Faxed Prescriptions
A ground-breaking partnership between DrFirst Healthcare Innovations (@DrFirst) and Applied Robotics Inc. will greatly improve patient safety and the efficiency with which pharmacies in Canada process faxed prescriptions. Based in British Columbia, Applied Robotics’ WinRx Pharmacy System platform is used by several hundred pharmacies in Canada. The WinRx platform now integrates DrFirst’s comprehensive SmartPharmacy solution – a first in Canada.
Products
ObjectiveHealth Launches ObjectiveScreen, an Artificial Intelligence-Powered Feasibility and Recruitment Platform to Optimize Clinical Trial Performance
ObjectiveHealth (@Objhealth), a Nashville-based integrated research and technology platform company, announced the launch of ObjectiveScreen, a cutting-edge artificial intelligence (AI) feasibility and recruitment platform that optimizes clinical trial performance and outcomes through superior patient identification, prequalification and retention.
LeanTaaS Announces iQueue Autopilot, First Ever Generative AI Hospital Operations Solution
LeanTaaS, Inc. (@LeanTaaS), a company providing AI-powered and SaaS-based capacity management, staffing, and patient flow software for health systems, announced the launch of iQueue Autopilot. This first-of-its-kind, generative AI solution for hospital operations will provide hospital leaders with human-like conversations and actionable insights to support decision-making for patient flow, scheduling, command center, block management, staffing, and other capacity management use cases across both inpatient and outpatient settings.
GE HealthCare Introduces Sonic DL: A Groundbreaking, FDA-Cleared AI Deep Learning Technology for Faster MRI
GE HealthCare (@GEHealthCare) announced the FDA clearance and launch of Sonic DL – a state-of-the-art deep learning-based technology designed to dramatically accelerate image acquisition in magnetic resonance imaging (MRI). Sonic DL enables new imaging paradigms, such as high-quality cardiac MRI in a single heartbeat. This breakthrough expands GE HealthCare’s industry-leading AI-enabled solutions portfolio.
Carbon Health Launches AI Charting in Its EHR Across All Clinics and Providers
Carbon Health (@CarbonHealth) announced the launch of hands-free charting — an AI-enabled notes assistant — in its proprietary EHR across each of its clinics and providers. Carbon Health’s EHR (electronic health records) platform is the first to deploy native AI-assisted charting at scale. With the patent-pending technology, Carbon Health has developed a way for providers to generate comprehensive and accurate medical notes more efficiently with the press of a record button.
Paige Introduces New AI-Based Biomarker Screening Advancement to Drastically Reduce Diagnostic Turnaround Times and Inform Precision Treatment Decisions
Paige (@paige_ai), a global company in end-to-end digital pathology solutions and clinical AI applications that assist in diagnosing cancer, announced a new AI-based digital assay to support pathologists in the detection and diagnosis of microsatellite instability (MSI) status in colon cancers. Paige Colon MSI operates on whole slide images of hematoxylin and eosin (H&E)-stained slides alone, offering slide-level classification of MSI status in colon cancer samples* based on morphologies associated with the presence or absence of MSI/MMR phenotype.
Tempus Announces Broad Launch of Tempus One
Tempus (@TempusLabs), a company in artificial intelligence (AI) and precision medicine, announced the upcoming broad launch of Tempus One – the first, AI-enabled clinical assistant that leverages advancements in generative AI to provide clinicians access to patient insights directly at their fingertips. Tempus One is a voice and text assistant – available via the Tempus Hub desktop and mobile app – that is designed to provide clinicians with quick access to their patient’s full clinical and molecular profile, along with an array of other datasets, which can be queried by physicians to help inform clinical decisions in real-time.
Esco Medical Selects Fairtility’s CHLOE EQ™ as AI Decision Support Tool for MIRI® Time-Lapse Incubators
Fairtility (@fairtility), the transparent AI innovator powering in vitro fertilization (IVF) for improved outcomes, announced that Esco Medical (@EscoMedical) has selected CHLOE EQ™ as the AI decision support tool to integrate with its MIRI® Time-Lapse Incubators (TLI). CHLOE EQ™ will provide its transparent AI embryo quality assessment capabilities, enabling explainable AI output to recommend embryos most likely to lead to implantation in an IVF cycle.
TeleVox Launches AI-Enabled Omnichannel Conversational Virtual Assistant for Healthcare Providers
TeleVox (@TeleVox_Health), a provider of omnichannel digital patient technology, unveiled its latest innovation at the HIMSS Conference this past April. Iris™, is the newest addition to the company’s end-to-end digital patient engagement platform, HouseCallsPro. Iris is a powerful AI-driven virtual agent accessible via web, voice and SMS interactions and embedded into HouseCalls Pro patient engagement workflows. Utilizing Microsoft Azure OpenAI Service with its large-scale, generative AI models and other chat technology, Iris provides patients with quick access to information and easy completion of common tasks, improving patient access and self-service.
To Read
Health care AI is here. So is new guidance to use it effectively. – By Timothy M. Smith, Contributing News Writer for AMA (@AmerMedicalAssn) – In a first for the U.S. health care industry, physicians and administrators in health care delivery settings have come together to create and disseminate continually updated best practices for implementing augmented intelligence (AI)—often called artificial intelligence—and to cultivate a community of practice. The Health AI Partnership is a collaboration among 14 health care organizations and ecosystem partners, including Duke Health, Mayo Clinic, the University of California at Berkeley, the AMA, and DLA Piper, a global law firm.